(19)
(11) EP 4 096 626 A1

(12)

(43) Date of publication:
07.12.2022 Bulletin 2022/49

(21) Application number: 21703623.5

(22) Date of filing: 27.01.2021
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 47/34(2017.01)
A61P 33/14(2006.01)
 A61K 47/10(2017.01)
A61P 33/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0017; A61K 47/10; A61K 47/34; A61P 33/14
(86) International application number:
PCT/EP2021/051891
(87) International publication number:
WO 2021/151963 (05.08.2021 Gazette 2021/31)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 29.01.2020 US 202062967281 P

(71) Applicant: Bayer Animal Health GmbH
51373 Leverkusen (DE)

(72) Inventors:
  • FROEHLICH, Anne
    51371 Leverkusen (DE)
  • TURBERG, Andreas
    42781 Haan (DE)
  • MENSINGER, Sandra
    50678 Köln (DE)
  • GRIZIC, Daris
    40229 Düsseldorf (DE)
  • GONDOL, Daniel
    42799 Leichlingen (DE)
  • BARTON, William
    Forest City Missouri, 64451 (US)

(74) Representative: Cohausz & Florack 
Patent- & Rechtsanwälte Partnerschaftsgesellschaft mbB Bleichstraße 14
40211 Düsseldorf
40211 Düsseldorf (DE)

   


(54) PHARMACEUTICAL COMPOSITION FOR CONTROLLING PARASITES ON NON-HUMAN ORGANISMS